Stay updated on Selinexor and Liposomal Doxorubicin in MM Clinical Trial
Sign up to get notified when there's something new on the Selinexor and Liposomal Doxorubicin in MM Clinical Trial page.

Latest updates to the Selinexor and Liposomal Doxorubicin in MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision now shows v3.3.2 instead of v3.2.0, and no clinical content or study data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the site-wide funding/operating-status banner and related notices. The notice previously directed users to cc.nih.gov and opm.gov for updates.SummaryDifference0.5%

- Check34 days agoChange DetectedThe screenshot changes show only updates to the record history list with no alterations to core study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference10%

- Check70 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update without substantive content changes.SummaryDifference0.3%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed.SummaryDifference0.6%

Stay in the know with updates to Selinexor and Liposomal Doxorubicin in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor and Liposomal Doxorubicin in MM Clinical Trial page.